Financial statements Bionexen

Balance sheet of Bionexen

Company age:
Age:
8 y. 1 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIONEXEN

Year
2017
2019
2020
2021
2022
2023
Total assets 4 127,33 9 091,40 32 341,98 290 098,72 246 094,71 239 424,60
A. Fixed assets 0,00 0,00 - - - -
B. Current assets 2 777,33 4 091,40 32 341,98 290 098,72 246 094,71 239 424,60
C. Share capital contributions (basic funds) 1 350,00 5 000,00 0,00 - - -
D. Own shares (stocks) - 0,00 - - - -
Total liabilities 4 127,33 9 091,40 32 341,98 290 098,72 246 094,71 239 424,60
A. Equity -22 691,37 -64 154,39 -53 446,73 174 426,12 143 084,11 131 630,30
B. Liabilities and provisions for liabilities 26 818,70 73 245,79 85 788,71 115 747,60 103 010,60 107 794,30
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.